Medtronic Plc

MDTNYSE · USD
88.51USD0.00 (-0.89%)
797

Medtronic Plc (MDT) Covered Calls

As of September 23, 2026, MDT has 124 covered call opportunities in the coming three months. Return ranges from 1.1 to 58.2% until expiration. Annualized return ranges from 6.4 to 2,188.8%. The nearest expiration is September 25, 2026. Maximum potential profit is $5,195.

Read more

Running MDT covered calls helps you generate consistent income from Medtronic Plc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Medtronic Plc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best MDT covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if MDT stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling MDT covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Medtronic Plc covered call is worth writing.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.

The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Income-focused investors, long-term MDT holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling MDT covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Medtronic Plc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile69.84% Elevated
  • Market cap (M$)113,216
  • 52 weeks high-16.76%
  • 52 weeks low20.73%
  • Analyst recommendationBuy
    1.79
  • Target price$104.00
    17.50% above the current stock price
  • Dividend—
  • Payout ratio76.20%
  • Earnings date2026-11-17
  • P/E21.79
  • Future P/E13.84
  • EPS (ttm)4.06
  • EPS growth next 5 years7.71%

As of September 23, 2026

2026-09-252100.0011.980.010.031071.0011.992188.77-0.01+0.011,0740.02
2026-09-25292.003.020.010.32271.003.03553.84-0.01+0.142510.31
2026-10-029100.0011.980.010.091071.0011.99486.39-0.01+0.037920.08
2026-10-1623110.0023.180.020.352072.0023.20368.22-0.02+0.042750.33
2026-09-25291.001.900.010.30171.001.91349.47-0.01+0.173870.29
2026-10-1623105.0017.580.050.251575.0017.64279.89-0.06+0.0523,6740.20
2026-10-02995.006.380.100.23580.006.49263.41-0.11+0.092,0730.13
2026-10-02994.005.260.020.43472.005.29214.36-0.02+0.12850.41
2026-09-25290.000.780.260.6296.001.08196.19-0.29+0.361,8890.36
2026-10-1623100.0011.980.200.341090.0012.21193.70-0.22+0.092,6160.14

As of September 23, 2026

Sell covered calls with the data behind you

Find the best MDT covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial